The aim of the study is to describe asthma phenotype with small airways dysfunction, in a multiparametric manner, with clinical, biological, morphological and genetic elements compared with asthma with proximal airways obstruction. The objective of this study is also to complete the clinical, immunobiological and morphological analysis of asthma with small airways dysfunction.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
11
symptoms, medical history, date of start, date of aggravation, comorbidities, increased factors related to asthma, blood eosinophils, blood periostin, allergologic patch test, igE analysis, tomodensitometric test.
symptoms, medical history, date of start, date of aggravation, comorbidities, increased factors related to asthma, blood eosinophils, blood periostin, allergologic patch test, IgE analysis, tomodensitometric test.
Cabinets de Pneumologie Liberale
Caluire-et-Cuire, France
Hospices Civils de Lyon
Lyon, France
CABINETS DE PNEUMOLOGIE LIBERALE HIA Desgenettes
Lyon, France
HC pneumo C
Pierre-Bénite, France
mRNA expression levels.
mRNA expression levels will be measured by microarray analysis.
Time frame: maximum 4 weeks after the inclusion visit.
clinical asthma profile : symptoms
symptoms
Time frame: maximum 4 weeks after the inclusion visit.
clinical asthma profile : medical history
medical history
Time frame: maximum 4 weeks after the inclusion visit.
clinical asthma profile : date of start
date of start
Time frame: maximum 4 weeks after the inclusion visit.
clinical asthma profile : date of aggravation
date of aggravation
Time frame: maximum 4 weeks after the inclusion visit.
clinical asthma profile : comorbidities
comorbidities
Time frame: maximum 4 weeks after the inclusion visit.
clinical asthma profile : increased factors related to asthma.
increased factors related to asthma.
Time frame: maximum 4 weeks after the inclusion visit.
biological asthma profile :blood eosinophils
blood eosinophils
Time frame: maximum 4 weeks after the inclusion visit.
biological asthma profile : blood periostin
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
blood periostin
Time frame: maximum 4 weeks after the inclusion visit.
biological asthma profile : allergologic patch test
allergologic patch test
Time frame: maximum 4 weeks after the inclusion visit.
biological asthma profile : IgE analysis
IgE analysis
Time frame: maximum 4 weeks after the inclusion visit.
morphological asthma profile : Chest X Ray (tomodensitometric test).
Chest X Ray (tomodensitometric test).
Time frame: maximum 4 weeks after the inclusion visit.